Displaying 289 - 300 items out of 317 results

Press release

Phase III Trial Finds Hypofractionated Radiotherapy with Chemotherapy Offers Comparable Survival and Lower Toxicity to Conventional Schedule in LS-SCLC

Press release

Spread Through Airspaces (STAS) Associated with Poor Prognosis in Early-Stage NSCLC Across Lobectomy and Segmentectomy Procedures

Press release

EA5181 Phase 3 Trial Finds No OS Benefit for Concurrent and Consolidative Durvalumab vs Consolidation Alone in Unresectable Stage 3 NSCLC

Press release

NADIM ADJUVANT Trial Suggests Benefit of Adjuvant Chemo-Immunotherapy in Resected Stage IB–IIIA NSCLC

Press release

Tarlatamab with Anti-PD-L1 as First-Line Maintenance After Chemo-Immunotherapy for ES-SCLC Demonstrates Acceptable Safety Profile and Unprecedented Overall Survival

Press release

Lung Cancer Screening Benefits Adults Up to Age 80 if Surgical Candidates, UK Study Finds

Press release

Video Assisted Thoracoscopy Surgery Reduces Mortality by 21 Percent Compared to Lobectomy

Press release

BMS-986504 Demonstrates Durable Responses in MTAP-Deleted NSCLC, Including EGFR and ALK-Positive Tumors

Press release

Novel Immunotherapy Strategy Shows Promising Long-Term Survival in Advanced NSCLC Patients with Inadequate Response to Immune Checkpoint Inhibitors

Press release

Circulating Tumor DNA May Guide Immunotherapy Use in Limited-Stage SCLC, New Study Shows

Press release

Surgery After EGFR TKI Shows Promise in Prolonging Progression-Free Survival in Metastatic NSCLC

Press release

New Research Identifies IFITM3 as Key Driver of Immunotherapy Response in Small Cell Lung Cancer